Literature DB >> 22234107

Moraxella catarrhalis as a respiratory pathogen.

Naveen Gupta1, Shamma Arora, Shailja Kundra.   

Abstract

BACKGROUND: Moraxella catarrhalis is gaining significance as a pathogen over few decades because of increased rate of isolation in respiratory specimens and due to emergence of multidrug resistant strains. Therefore, appropriate antimicrobial agents are required for eradication and prevention of spread of the organism.
MATERIAL AND METHODS: The study was conducted over 1-year period inpatients of lower respiratory tract infections (L.R.T.I.) in P.G.I.M.S. Rohtak (Haryana) . Assessment of clinical significance of M.catarrhalis was ascertained on the basis of preformed criteria.
RESULTS: A total of 63 clinically significant M. catarrhalis were isolated from a tertiary care hospital. The isolates showed maximum resistance to cotrimoxazole (82.5%), penicillin (77.7%), and ampicillin (71.4%) while susceptibility was maximum to cefotaxime (87.3%) followed by tetracycline (85.7%) ciprofloxacin (84.1%), erythromycin (80.9%) amikacin (79.3%), gentamycin (77.7%), and cefazolin (76.2%). Multidrug resistance to >3 antimicrobials was seen in 22 (34.9%) of cases.
CONCLUSIONS: Predominant or pure growth of M.catarrhalis in throat swabs from cases of L.R.T.I. should be reported and treated by microbiologist and clinician respectively. Antibiotic therapy should be decided based on sensitivity report for rapid response and recovery of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22234107     DOI: 10.4103/0377-4929.91496

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

1.  Infectious endocarditis and vertebral osteomyelitis caused by Moraxella catarrhalis.

Authors:  Serban M Maierean; Daniel C Marinescu; David O Croitoru; Amol A Verma
Journal:  BMJ Case Rep       Date:  2019-05-24

Review 2.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

3.  RNA-Seq-based analysis of the physiologic cold shock-induced changes in Moraxella catarrhalis gene expression.

Authors:  Violeta Spaniol; Stefan Wyder; Christoph Aebi
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

4.  Alternations in DNA gyrase genes in low-level fluoroquinolone-resistant Moraxella catarrhalis strains isolated in Poland.

Authors:  Katarzyna Król-Turmińska; Alina Olender
Journal:  Infect Drug Resist       Date:  2018-08-06       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.